Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD201720182020202120222023
Revenues--<1m<1m1.2m1.4m
% growth---13 %167 %13 %
EBITDA(<1m)(<1m)----
Profit(<1m)(<1m)----
  • Edit
DateInvestorsAmountRound

N/A

Series A
N/A

$500k

Valuation: $3.0m

-10.2x EV/LTM EBITDA

Seed

£518k

Valuation: £2.5m

Seed

N/A

Support Program
Total FundingCAD1.6m

Recent News about Gendius

Edit
More about Gendiusinfo icon
Edit

Gendius operates in the digital health sector, focusing on diabetes management through its flagship platform, Intellin. The company serves individuals with diabetes and healthcare professionals, primarily within the NHS framework. Intellin allows users to track their diabetes and make informed decisions to mitigate the risk of complications. The platform integrates with over 150 health apps and devices, including blood glucose monitors, blood pressure monitors, and fitness trackers, enhancing its utility and reach. Users can also share their health data with family, friends, or healthcare providers, fostering a collaborative approach to diabetes management. Gendius generates revenue through subscriptions and partnerships with healthcare organizations. The business model leverages digital technology to provide validated, evidence-based advice and personalized health insights. This approach aligns with the NHS's five-year plan to incorporate appropriate digital solutions into healthcare.

Keywords: diabetes management, digital health, personalized assistant, health tracking, NHS integration, health data sharing, blood glucose monitors, fitness trackers, healthcare professionals, evidence-based advice.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.